Journal of Neuroscience · 2008 · 86 citations · 39 references
Life SciencesDevelopmental BiologyNeuroscienceDevelopmental NeuroscienceMolecular NeuroscienceSignal TransductionCell Signaling In NeuronsDevelopmental Signaling PathwaysNeural Circuit FormationNeural DevelopmentNeuronal DevelopmentAnaphase-promoting ComplexAnaphase-promoting Complex SignalingEpistasis AnalysisNeural Development SignalingNeuronal ConnectivitySmad Signaling PathwaySmad-mediated Signal TransductionTransforming Growth Factor-beta Signaling
Axon growth is critical to the establishment of neuronal connectivity. The E3 ubiquitin ligase Cdh1-anaphase-promoting complex (Cdh1-APC) and its substrate the transcriptional modulator SnoN form a cell-intrinsic pathway that orchestrates axonal morphogenesis in the mammalian brain. How the Cdh1-APC/SnoN pathway is controlled in the nervous system remained unknown. Here, we report that the TGFbeta-regulated signaling protein Smad2 plays a key role in regulating the Cdh1-APC/SnoN pathway in neurons. We find that Smad2 is expressed in primary granule neurons of the developing rat cerebellar cortex. The Smad signaling pathway is basally activated in neurons. Endogenous Smad2 is phosphorylated, localized in the nucleus, and forms a physical complex with endogenous SnoN in granule neurons. Inhibition of Smad signaling by several distinct approaches, including genetic knock-down of Smad2, stimulates axonal growth. Biochemical evidence and genetic epistasis analyses reveal that Smad2 acts upstream of SnoN in a shared pathway with Cdh1-APC in the control of axonal growth. Remarkably, Smad2 knock-down also overrides the ability of adult rat myelin to inhibit axonal growth. Collectively, our findings define a novel function for Smad2 in regulation of the Cdh1-APC/SnoN cell-intrinsic pathway of axonal morphogenesis, and suggest that inhibition of Smad signaling may hold therapeutic potential in stimulating axonal growth after injury in the CNS.
39
Gareth J. Inman, Francisco José Nicolás, James F. Callahan et al. · Molecular Pharmacology · 2002 · 1.7K citations
Smad6 inhibits signalling by the TGF-β superfamily
Takeshi Imamura, Masao Takase, Ayako Nishihara et al. · Nature · 1997 · 1K citations